Key Provisions of the Bill
House Bill 7065 proposes to reclassify the possession of up to half an ounce of psilocybin from a criminal offense to a civil infraction. Under the current law, such possession can result in up to a year in jail and a $2,000 fine. The proposed legislation would instead impose a $150 fine for first-time offenses, with subsequent violations attracting fines between $200 and $500. Notably, the bill does not legalize psilocybin but seeks to reduce the penalties associated with its possession.
Additionally, the bill stipulates that minors found in possession of psilocybin would not be adjudicated delinquent on first or second offenses. However, it does not mandate counseling or treatment programs for underage individuals, a point that has drawn criticism from some lawmakers.
Support and Opposition
Proponents of the bill, including Judiciary Committee Co-Chair Rep. Steve Stafstrom (D-Bridgeport), argue that psilocybin has demonstrated therapeutic potential for mental health conditions such as PTSD, depression, and anxiety. They contend that decriminalization could facilitate further research and reduce the stigma associated with its use.
Opponents, however, express concerns about public safety and the message decriminalization sends. House Minority Leader Vincent Candelora (R-North Branford) warned that the bill could lead to increased accessibility of psilocybin among minors, drawing parallels to the state’s experience with cannabis legalization. He also criticized the absence of mandatory counseling provisions for underage offenders.
Governor’s Stance and Legislative Outlook
Governor Ned Lamont has previously expressed reservations about broad decriminalization measures for psychedelics. While he has not issued a definitive statement on HB 7065, his past opposition to similar bills suggests potential challenges ahead.
The bill’s future in the Senate remains uncertain. A similar measure passed the House in 2023 but failed to advance in the Senate. With the current legislative session set to adjourn on June 4, the window for Senate approval is narrowing.
Broader Context
Connecticut’s move aligns with a growing national conversation around the decriminalization and medical use of psychedelics. States like Oregon and Colorado have already implemented measures to decriminalize or regulate psilocybin use, particularly for therapeutic purposes. However, the approach varies widely across states, reflecting differing public sentiments and policy priorities.
As Connecticut lawmakers deliberate on HB 7065, the outcome could signal the state’s position in the evolving landscape of drug policy reform.
Dabbin-Dad Newsroom
If you liked this post, say thanks by sharing it
